Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Cosmi

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Heart Failure|June 1, 2018
Risk stratification according to insulin type: replyFranco Cosmi, Lidia Staszewsky, John J V McMurray, et al.
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[From medical statistics to medical stochastics]Franco Cosmi, Mauro Antimi, Rosario Brischetto, et al.
Giornale Italiano Di Cardiologia (2006)|March 24, 2020
[The patient in clinical research: disposable guinea pig or involved actor?]Franco Cosmi, Beatrice Mariottoni, Barbara Tarquini, et al.
Journal of the American College of Cardiology|February 7, 2006
Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trialLeonardo Bolognese, Giovanni Falsini, Francesco Liistro, et al.
American Heart Journal|May 4, 2010
Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trialMarcello Disertori, Federico Lombardi, Simona Barlera, et al.
Metabolism: Clinical and Experimental|February 26, 2018
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trialAlessandro Mantovani, Giovanni Targher, Pier Luigi Temporelli, et al.
Journal of the American Heart Association|July 7, 2017
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) TrialMarco Dauriz, Giovanni Targher, Pier Luigi Temporelli, et al.
BMC Cardiovascular Disorders|April 17, 2013
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trialMarcello Disertori, Maria Grazia Franzosi, Simona Barlera, et al.
European Heart Journal|September 1, 2009
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trialAldo P Maggioni, Gianna Fabbri, Donata Lucci, et al.
European Heart Journal|June 14, 2011
Clinical outcome of renal tubular damage in chronic heart failureKevin Damman, Serge Masson, Hans L Hillege, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Heart Failure|June 1, 2018
Risk stratification according to insulin type: replyFranco Cosmi, Lidia Staszewsky, John J V McMurray, et al.
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[From medical statistics to medical stochastics]Franco Cosmi, Mauro Antimi, Rosario Brischetto, et al.
Giornale Italiano Di Cardiologia (2006)|March 24, 2020
[The patient in clinical research: disposable guinea pig or involved actor?]Franco Cosmi, Beatrice Mariottoni, Barbara Tarquini, et al.
Journal of the American College of Cardiology|February 7, 2006
Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trialLeonardo Bolognese, Giovanni Falsini, Francesco Liistro, et al.
American Heart Journal|May 4, 2010
Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trialMarcello Disertori, Federico Lombardi, Simona Barlera, et al.
Metabolism: Clinical and Experimental|February 26, 2018
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trialAlessandro Mantovani, Giovanni Targher, Pier Luigi Temporelli, et al.
Journal of the American Heart Association|July 7, 2017
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) TrialMarco Dauriz, Giovanni Targher, Pier Luigi Temporelli, et al.
BMC Cardiovascular Disorders|April 17, 2013
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trialMarcello Disertori, Maria Grazia Franzosi, Simona Barlera, et al.
European Heart Journal|September 1, 2009
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trialAldo P Maggioni, Gianna Fabbri, Donata Lucci, et al.
European Heart Journal|June 14, 2011
Clinical outcome of renal tubular damage in chronic heart failureKevin Damman, Serge Masson, Hans L Hillege, et al.
Pageof 5